Table 2.
Clinical characteristics of participants as per MetS status.
| Characteristic | Overall N = 302 | MetS (N = 71) | No MetS (N = 231) | p-value |
|---|---|---|---|---|
| n/N (%) | n/N (%) | n/N (%) | ||
| HIV status | 0.998 | |||
| Negative | 268 (88.74) | 63 (88.73) | 205 (88.74) | |
| Positive | 34 (11.26) | 8 (11.27) | 26 (11.26) | |
| Weight, kg (mean ± SD) | 68.18 (±14.14) | 79.86 (±13.72) | 64.73 (±12.24) | <0.001∗ |
|
| ||||
| Mental illness | 0.971 | |||
| BAD | 192 (63.58) | 46 (64.79) | 146 (63.20) | |
| Schizophrenia | 79 (26.16) | 18 (25.35) | 61 (26.41) | |
| Depression | 31 (10.26) | 07 (9.86) | 24 (10.39) | |
|
| ||||
| Duration of mental illness (years) | <0.001∗ | |||
| <5 | 138 (45.70) | 24 (33.80) | 114 (49.35) | |
| 5–10 | 68 (22.52) | 09 (12.68) | 59 (25.54) | |
| >10 | 96 (31.79) | 38 (53.52) | 58 (25.11) | |
|
| ||||
| Duration of psychotropic medication (years) | 0.001∗ | |||
| <5 | 147 (48.68) | 28 (39.44) | 119 (51.52) | |
| 5–10 | 88 (29.14) | 33 (46.48) | 55 (23.81) | |
| >10 | 67 (22.19) | 10 (14.08) | 57 (24.68) | |
|
| ||||
| Antipsychotic medication | 247 (81.79) | 56 (78.87) | 191(82.68) | 0.467 |
|
| ||||
| Antipsychotic class (N = 247) | 0.098 | |||
| Typical | 232 (93.93) | 50 (89.29) | 182 (95.29) | |
| Atypical | 15 (6.07) | 06 (10.71) | 09 (4.71) | |
| Mood stabilizer | 161 (53.31) | 34 (47.89) | 127 (54.98) | 0.295 |
| Antidepressant | 56 (18.54) | 18 (25.35) | 38 (16.45) | 0.091 |
Note. BAD: bipolar disorder; MetS: metabolic syndrome; hx: history; ∗statistically significant.